Email ID
Sign me in automatically next time
First filing for Astellas' SGLT2 inhibitor contender ipragliflozin, in Japan

Astellas has landed the first blow in what will be a highly competitive market for sodium-glucose co-transporter 2 (SGLT2) inhibitors in Japan, with an approval filing for ipragliflozin (ASP1941) for...
14 March 2013
Ian Haydock

Please Login to read the full article.
04 April 2016
Stockholm, Sweden
06 April 2016
Hamburg, Germany
JOB OF THE WEEK Promote your job vacancy
© 2016 Informa plc. All rights reserved.
This site is owned and operated by Informa plc ("Informa") whose registered office is Mortimer House, 37-41 Mortimer Street, London, W1T 3JH. Registered in England and Wales. Number 3099067. UK VAT Group: GB 365 4626 36